Ardelyx Inc reports results for the quarter ended December 31 - Earnings Summary

Ardelyx

20/02/2025 14:46

* Ardelyx Inc  ARDX.OQ  reported quarterly adjusted earnings
of 2
cents​​ per share for the quarter ended December 31, higher than
the same quarter last year, when the company reported EPS of -12
cents.  The mean expectation of nine analysts for the quarter
was for breakeven results per share. Wall Street expected
results to range from -5 cents to 4 cents per share.
    * Revenue rose 237.9% to $116.13 million from a year ago;
analysts
expected $109.94 million. 
    * Ardelyx Inc's reported EPS for the quarter was 2 cents​.
    * The company reported quarterly net income of $4.65
million.
    * Ardelyx Inc shares had risen by 25.4% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 1,503%
in the last three months.​ 
    * In the last 30 days, two analysts negatively revised
earnings
estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Ardelyx Inc is
$10.50 
This summary was machine generated from LSEG data February 20 at
02:45 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2024      0.00           0.02           Beat
 Sep. 30 2024      -0.05          0.00           Beat
 Jun. 30 2024      -0.11          -0.07          Beat
 Mar. 31 2024      -0.15          -0.11          Beat